AJP - Endo AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (July 25, 2006). doi:10.1152/ajpendo.00480.2005
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
291/6/E1372    most recent
00480.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, C.-S. J.
Right arrow Articles by Mountjoy, K. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, C.-S. J.
Right arrow Articles by Mountjoy, K. G
Submitted on October 3, 2005
Accepted on July 15, 2006

Peripherally administered desacetyl-{alpha}-MSH and {alpha}-MSH both influence post-natal rat growth and associated rat hypothalamic protein expression

Chia-Shan Jenny Wu1, David R Greenwood2, Janine M Cooney3, Dwayne J Jensen3, Michele A Tatnell1, Garth J.S. Cooper4, and Kathleen G Mountjoy5*

1 Physiology, University of Auckland, Auckland, New Zealand
2 MtAlbert, HortResearch, Auckland, New Zealand
3 Ruakura, HortResearch, Hamilton, New Zealand
4 School of Biological Sciences, University of Auckland, Auckland, New Zealand
5 Physiology, University of Auckland, Auckland, New Zealand; Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand

* To whom correspondence should be addressed. E-mail: kmountjoy{at}auckland.ac.nz.

Desacetyl-{alpha}-MSH predominates over {alpha}-MSH during development but whether it is biologically active and has a physiological role is unclear. We compared the effects of 0.3µg/g/day desacetyl-{alpha}-MSH with that of 0.3µg/g/day {alpha}-MSH on postnatal body growth by administering the peptides subcutaneously daily for postnatal days 0-14 and also used a 2DE-gel based proteomic approach to analyse protein changes in hypothalami, the relay centre for body weight and growth regulation, after 14 days of treatment. We found the growth rate between days 1-10 was significantly decreased by desacetyl-{alpha}-MSH but not by {alpha}-MSH, but by day 14, a time reported for development of a mature pattern of hypothalamic innervation, both peptides had significantly increased neonatal growth compared to PBS treated control rats. Desacetyl-{alpha}-MSH significantly increased spleen weight but {alpha}-MSH had no effect. Alpha-MSH significantly decreased kidney weight but desacetyl-{alpha}-MSH had no effect. Both desacetyl-{alpha}-MSH and {alpha}-MSH significantly decreased brain weight. By 14 days both peptides significantly changed expression of a number of hypothalamic proteins, specifically metabolic enzymes, cytoskeleton, signalling and stress response proteins. We show that peripherally administered desacetyl-{alpha}-MSH is biologically active and induces responses that can differ from those for {alpha}-MSH. In conclusion, desacetyl-{alpha}-MSH appears to be an important regulator of neonatal rat growth.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.